Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Gritstone bio Inc GRTSQ

Healthcare Biotechnology
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:GRTSQ)

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

GlobeNewswire November 11, 2024

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure

Business Wire October 10, 2024

Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer

GlobeNewswire September 30, 2024

Investors Have The Opportunity To Lead The Gritstone bio, Inc. Securities Fraud Lawsuit With The Schall Law Firm

ACCESS Newswire August 15, 2024

Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire August 13, 2024

Investors Are Invited To Take The Lead In The Gritstone Bio Inc Securities Fraud Case With The Schall Law Firm

ACCESS Newswire August 7, 2024

GRTS Investors Have The Opportunity To Lead Gritstone Bio Inc Securities Fraud Lawsuit With The Schall Law Firm

ACCESS Newswire August 6, 2024

Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - GRTS

ACCESS Newswire August 6, 2024

GRTS DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important August 6 Deadline in Securities Class Action - GRTS

Newsfile August 6, 2024
View More News ››

Opinion & Analysis (GREY:GRTSQ)

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

Streetwise Reports May 27, 2019
View More Opinion ››

Bullboard Posts (GREY:GRTSQ)

Market Perform Recommendation Issued On GRTS By JMP Securiti

JUST IN: $GRTS Market Perform Recommendation Issued On GRTS By JMP Securities2024-10-01 06:15:08 ET JMP Securities analyst issues MARKET...
whytestocks - October 1, 2024

GRTS Price Target Alert: $3.00. Issued by BTIG

JUST IN: $GRTS GRTS Price Target Alert: $3.00. Issued by BTIG2024-04-02 17:00:03 ET Kaveri Pohlman from BTIG issued a price target of $3...
whytestocks - April 2, 2024

Should Gritstone Bio be a part of your Investment Portfolio?

$GRTS Gritstone Bio a clinical-stage biotechnology company has a very interesting pipeline of candidates targeting Oncology and...
AviseAnalytics - August 23, 2021

WHAT?! Missed it - buying their cousin IPA ImmunoPrecise

I happened to look at this stock last week and never came back to it - I am now loading up on their cousin  IPA  ...
db2067 - January 20, 2021
View more Bullboard ››

Electrum Discovery Corp.

Electrum Discovery Corp.

Electrum Discovery Corp., formerly Medgold Resources Corp., is a Canada-based mineral exploration and development company ...
View More »